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Definition                                           
Chronic Hepatitis  
Chronic hepatitis (CH) is defined as inflammatory disease of 
the liver lasting for more than six months with common 
causes include hepatitis B and C viruses, autoimmune liver 
disease (autoimmune hepatitis), steatohepatitis (nonalcoholic 
steatohepatitis or alcoholic hepatitis), and some drugs, 
characterized by liver enzymes elevation, the presence of 
autoantibodies, elevated gamma globulin and other proteins 
levels, interface hepatitis on histology, and may occur with 
limited or no symptoms, but often leads to yellow 
discoloration of the skin, mucus membranes, and 
conjunctivae, poor appetite and malaise, with progress to 
fibrosis (scarring) and cirrhosis. 
http://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/hepatitis/overview-of-chronic-hepatitis 
USMLE TEST 
 A 56-year-old former intravenous drug user presents for his 
routine appointment at the infectious disease clinic. He was 
diagnosed 5 years ago with hepatitis C and is followed closely. 
He has had multiple liver biopsies that have yet to show 
cirrhotic changes. His current liver function tests (LFTs) are: 
AST: 25 IU/L and ALT: 40 IU/L. What is the most appropriate 
next step in the management of this patient?   
1.  No treatment indicated, 2.  Treatment with ribavarin, 
3.  Treatment with interferon, 4.  Liver transplantation, 
5.  Treatment with sofosbuvir  
 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 5   
This patient has chronic hepatitis C with normal liver enzymes and 
stable findings on biopsy. Previously, no treatment would have been 
indicated due to extensive side effects; however, the development of 
new antiviral drugs such as sofosbuvir have shown great efficacy in 
clearing the virus with minimal side effects. 
Incorrect answers: 
Whereas old treatments may have been withheld due to their side 
effects, this is no longer the standard of care, 2 and 3: Ribavirin and 
interferon are both treatments that were previously used and are no 
longer the mainstay of treatment. They are important to know because 
they may still be on the boards, 4: With normal LFTs it is unlikely that 
this patient has developed liver cirrhosis; therefore, he is not a 
candidate for transplantation. 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Epidemiology                                           
Chronic Hepatitis  
• Worldwide, viral hepatitis is the most common cause, 
followed closely by alcoholic liver disease and non-alcoholic 
fatty liver disease (NAFLD) 
• Chronic hepatitis B is estimated up to 240 million people in 
the world  
• Chronic hepatitis C  is estimated up to 180 million people in 
the world  
• Other less common causes of hepatitis 
include autoimmune diseases, poisoning especially 
through toxication, certain medications (such 
as paracetamol), some industrial organic solvents, and 
plants. 
https://en.wikipedia.org/wiki/Hepatitis#Epidemiology 
Epidemiology                                           
Chronic Hepatitis: Hepatitis B Virus Infection  
http://www.medsci.org/v02p0050.htm 
Epidemiology                                           
Chronic Hepatitis: Hepatitis C Virus Infection  
http://www.ourmed.org/images/1/1f/Cdchepctransmission.jpg s-media-cache-ak0.pinimg.com/236x/32/7f/52/327f52a6cce62062ab436675e03dfafe.jpg 
Risk Factors                                         
Chronic Hepatitis 1  
• Infectious agents 
• Sex female 
• Tattooing history 
• Endoscopy, major surgery  
• Phlebotomy, intravenous Drug Use 
• High risk job included nurse and barber 
• Dentist visit  
• Obesity 
file:///C:/Users/asus/Downloads/JJM_Issue_14,_267-272.pdf 
Risk Factors                                         
Chronic Hepatitis 2 
 
• Dyslipidemia 
• Glucose intolerance 
• Excessive alcohol consumption 
• More than 900 drugs, toxins, and herbs 
file:///C:/Users/asus/Downloads/JJM_Issue_14,_267-272.pdf 
Etiology                                              
Chronic Hepatitis  
• Infectious ((hepatitis B, C, D; parasitic hepatitis; bacterial 
hepatitis) 
• Metabolic (alcoholic hepatitis, toxic and drug-induced 
hepatitis, non-alcoholic fatty liver disease) 
• Ischemic (due to insufficient blood or oxygen) 
• Autoimmune (an abnormal immune response against liver 
cells, often with other autoimmune diseases) 
• Genetic ( alpha-1-antitrypsin deficiency, hemochromatosis, 
Wilson disease (autosomal recessive inherited disorder of 
copper metabolism)) 
• Other 
 
https://en.wikipedia.org/wiki/Hepatitis#Metabolic 
Etiology                                              
Chronic Hepatitis: Viruses  
https://en.wikipedia.org/wiki/Viral_hepatitis 
HBV HCV HDV 
Transmission Parenteral Parenteral Parenteral 
Classification Orthohepadnavirus Hepacivirus Deltavirus 
Genome dsDNA-RT +ssRNA −ssRNA 
Antigens HBsAg,HBeAg Core antigen Delta antigen 
Incubation 
period 
45–160 days 15–150 days 30–60 days 
Severity/Chronici
ty[4] 
occasionally 
severe; 5–10% 
chronic 
subclinical; 70% 
chronic 
exacerbates 
symptoms of 
HBV; chronic w/ 
HBV 
Vaccine 
3 injections, 
lifetime protection 
None available None available 
Etiology                                               
Chronic Hepatitis: Hepatitis B Particle Types 1   
http://www.hepatitisbviruspage.com/hb 
• The hepatitis B virion (HBV, the Dane particle) has a 
diameter around 42nm 
• The outer envelope contains high amounts of 
hepatitis B surface proteins .    
Etiology                                               
Chronic Hepatitis: Hepatitis B Particle Types 2  
http://www.hepatitisbviruspage.com/hb 
• The envelope surrounds the inner nucelocapsid 
which is comprised of 180 hepatitis B core proteins 
arranged in an icosahedral arrangement with T=3 
and T=4 symmetry  
Etiology                                               
Chronic Hepatitis: Hepatitis B Particle Types 3  
http://www.hepatitisbviruspage.com/hb 
• The nucleocapsid also contains at least one 
hepatitis B polymerase protein as well as the HBV 
genome  
Etiology                                               
Chronic Hepatitis: Hepatitis B Particle Types 4  
http://www.hepatitisbviruspage.com/hb 
• Two other subviral particles can be found in an 
infected individual's serum, namely the hepatitis B 
filament and hepatitis B sphere (a diameter of 
22nm) that are composed solely of hepatitis B 
surface proteins without infectious nature.    
Etiology                                               
Chronic Hepatitis: Hepatitis C Particle Types 1   
http://www.hepatitisbviruspage.com/hb 
• The hepatitis C virus (HCV) particle consists of a 
core of genetic material (RNA), surrounded by an 
icosahedral protective shell of protein, and further 
encased in a lipid (fatty) envelope of cellular origin  
Etiology                                               
Chronic Hepatitis: Hepatitis C Particle Types 2   
http://www.hepatitisbviruspage.com/hb 
• Two viral envelope glycoproteins, E1 and E2, are 
embedded in the lipid envelope  
Etiology                                               
Chronic Hepatitis: Hepatitis C Particle Types 3 
http://www.hepatitisbviruspage.com/hb 
• The virus replicates mainly in the hepatocytes of the 
liver, where it is estimated that daily each infected 
cell produces approximately fifty virions with a 
calculated total of one trillion virions generated  
Etiology                                               
Chronic Hepatitis: Hepatitis C Particle Types 4 
http://www.hepatitisbviruspage.com/hb 
• The virus may also replicate in peripheral blood 
mononuclear cells, potentially accounting for the 
high levels of immunological disorders found in 
chronically infected HCV patients.   
Etiology                                               
Chronic Hepatitis: Hepatitis D Particle Types 1  
http://www.hepatitisbviruspage.com/hb 
• In 1977, an Italian doctor named Mario Rizzetto 
discovered a new nuclear antigen in the liver cells of 
patients infected with Hepatitis B Virus (HBV)  
Etiology                                               
Chronic Hepatitis: Hepatitis D Particle Types 2  
http://www.hepatitisbviruspage.com/hb 
• The antigen was thought to be a new protein 
encoded by HBV, and it was labeled as the delta 
antigen  
Etiology                                               
Chronic Hepatitis: Hepatitis D Particle Types 3 
http://www.hepatitisbviruspage.com/hb 
• Subsequent research on chimpanzees, however, 
indicated that this antigen was derived from a new 
virus, named the Hepatitis Delta Virus (HDV)  
Etiology                                               
Chronic Hepatitis: Hepatitis D Particle Types 4 
http://www.hepatitisbviruspage.com/hb 
• HDV is not classified into a viral family because it is 
a unique virus dependent on HBV.  
Etiology                                               
Chronic Hepatitis  
Hepatitis B transmitted vertically in areas of high 
incidence (perinatally) from mother to baby during 
birth) or horizontally by being exposed to infected 
blood or blood products or less common through 
exposure to mucous membranes 
Hepatitis C  transmitted in same ways and has 
become the most common viral hepatitis since 
widespread vaccination for Hepatitis B in the 
mid1980s.  
 en.wikipedia.org/wiki/Hepatitis  
USMLE TEST 
A 64-year-old Vietnam veteran who has just moved to the 
area from another state presents to a primary care physician 
to establish care. The patient reports that his only medical 
issue is hypertension for which he takes hydrochlorothiazide. 
He recalls only one prior hospitalization (he jokes that it was 
on his 20th birthday in 1971) for gallbladder surgery and 
received a blood transfusion. Because of his transfusion 
history, for which of the following should this patient be 
screened?   
1.  Hepatitis B, 2.  Hepatitis C, 3.  Hepatitis B & C, 4.  Post-
transfusion purpura, 5.  HIV infection  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 3   
This patient should be screened for hepatitis B and hepatitis C. 
Individuals who received a blood transfusion before 1992 should be 
screened for hepatitis C and individuals who received transfusions 
before 1986 should be screened for hepatitis B. 
Incorrect answers: 
1 & 2: This individual received a blood transfusion in the late 1960s, 
necessitating that he be screened for both hepatitis B and C, 4: Post-
transfusion purpura is a non-infectious complication of blood 
transfusions resulting in sudden severe thrombocytopenia developing 
about 9 days following transfusion. This is not relevant to this patient, 5: 
The first reported cases of transfusion-related HIV were not noted until 
the 1980s. This patient's blood transfusion took place far before that 
time. 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Mechanisms                                      
Chronic Hepatitis 1  
• The specific mechanism varies and depends on the 
underlying cause 
• In viral hepatitis, the presence of the virus causes 
the immune system to attack the liver, resulting in 
inflammation and impaired function 
• In autoimmune hepatitis, the immune system 
attacks the liver due to the autoimmune disease 
• In some hepatitis, often including hepatitis caused 
by alcoholism, fat deposits accumulate in the liver, 
resulting in fatty liver disease (steatohepatitis)  
en.wikipedia.org/wiki/Hepatitis 
Mechanisms                                      
Chronic Hepatitis 2 
• Chronic hepatitis in severe cases is occurring  with 
portal based inflammation, fibrosis, disruption of 
the terminal plate, and piecemeal necrosis 
• Chronic hepatitis without piecemeal necrosis 
(formerly called chronic persistent hepatitis) has no 
significant periportal necrosis or regeneration with 
a fairly dense mononuclear portal infiltrate.  
en.wikipedia.org/wiki/Hepatitis 
Mechanisms                                      
Chronic Hepatitis: NK Cell-mediated Lysis   
http://www.diapedia.org/img_cache/markdown_lightbox_e0b0ff34f8a4890e9e50cc52cd13677635908c1c-239fe.jpg 
NK cell-mediated lysis of intrahepatic cells involved in the 
pathogenesis of viral hepatitis. 
Mechanisms                                      
Chronic Hepatitis: Fueling Fibrosis  
en.wikipedia.org/wiki/Hepatitis  
Classification  
International Classification of Diseases   
https://www.tsoshop.co.uk/productimages/default.aspx?ISBN=9789241549165&FORMAT=3  http://apps.who.int/classifications/icd10/browse/2016/en#/XI 
XI Diseases of the digestive 
B18 Chronic viral hepatitis 
K70 Alcoholic liver disease 
K71 Toxic liver disease 
K73 Chronic hepatitis, not elsewhere 
classified 
K74 Fibrosis and cirrhosis of liver 
K75 Other inflammatory liver diseases 
Classification  
Chronic Hepatitis    
 Cases of CH were once classified histologically as 
chronic persistent, chronic lobular, or chronic active 
hepatitis 
A more useful recent classification system specifies 
the following: 
• Etiology 
• Intensity of histologic inflammation and necrosis 
(grade) 
• Degree of histologic fibrosis (stage) 
• Inflammation and necrosis are potentially 
reversible; fibrosis usually is not. 
http://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/hepatitis/overview-of-chronic-hepatitis 
USMLE TEST 
A 32-year-old male with a long history of injection drug use is 
seen in your clinic complaining of fatigue and loss of appetite. 
Physical exam is largely unremarkable. Tests reveal serum 
positive for anti-HCV antibodies and positive HCV RNA. Which 
of the following tests will give the best information regarding 
the patient's prognosis?  
1.  Liver ultrasound, 2.  Liver biopsy, 3.  Physical exam, 
4.  AST:ALT ratio, 5.  AST only  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 2   
This patient likely has chronic hepatitis C infection. Liver biopsy is 
the most appropriate test to determine the extent of fibrosis and 
liver damage in individuals with chronic hepatitis.  
Incorrect answers: 
1: Hepatic ultrasound can be negative in cases where biopsy shows 
disease histologically, therefore it is not a sensitive diagnostic test, 
3: Alkaline phosphatase is an enzyme in cells that line the liver 
biliary ducts, and so is a marker of cholestatic disease or bile duct 
obstruction but not particularly appropriate for assessing fibrosis, 
4-5: Levels of ALT and AST can vary widely and be normal or 
elevated in patients with chronic hepatitis, so they are not a good 
marker of progression of disease. 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Signs and Symptoms                                      
Chronic Hepatitis 1 
• About 1/3 of cases develop after acute hepatitis, 
but most develop insidiously de novo  
• Many patients are asymptomatic, especially in 
chronic HCV infection 
• Malaise, anorexia, and fatigue are common, 
sometimes with low-grade fever and nonspecific 
upper abdominal discomfort  
http://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/hepatitis/overview-of-chronic-hepatitis 
Signs and Symptoms                                      
Chronic Hepatitis 2 
• Often, particularly with HCV, the first findings are 
signs of chronic liver disease and cirrhosis  (e.g., 
splenomegaly, spider nevi, palmar erythema, portal 
hypertension, ascites, encephalopathy) 
• A few patients develop manifestations of 
cholestasis (e.g., jaundice, pruritus, pale stools, 
steatorrhea)  
http://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/hepatitis/overview-of-chronic-hepatitis 
Signs and Symptoms                                      
Chronic Hepatitis 3 
• In autoimmune hepatitis, especially in young 
women, manifestations may involve virtually any 
body system and can include acne, amenorrhea, 
arthralgia, ulcerative colitis, pulmonary fibrosis, 
thyroiditis, nephritis, and hemolytic anemia  
• Chronic HCV is occasionally associated with lichen 
planus, mucocutaneous vasculitis, 
glomerulonephritis, porphyria cutanea tarda, and, 
perhaps, non-Hodgkin B-cell lymphoma   
http://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/hepatitis/overview-of-chronic-hepatitis 
Signs and Symptoms                                      
Chronic Hepatitis 4 
• About 1% of patients develop symptomatic 
cryoglobulinemia with fatigue, myalgias, arthralgias, 
neuropathy, glomerulonephritis, and rashes 
(urticaria, purpura, leukocytoclastic vasculitis); 
asymptomatic cryoglobulinemia is more common. 
http://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/hepatitis/overview-of-chronic-hepatitis 
Clinical Investigation                                                  
Chronic Hepatitis 1 
• CH is commonly identified on blood tests 
performed either for screening or to evaluate 
nonspecific symptoms 
• The presence of jaundice indicates advanced liver 
damage 
• On physical examination there may be enlargement 
of the liver 
• Extensive damage leads to weight loss, easy 
bruising and bleeding, peripheral edema (swelling 
of the legs), and accumulation of ascites  
en.wikipedia.org/wiki/Hepatitis  
Clinical Investigation                                                  
Chronic Hepatitis 2 
• Acne, abnormal menstruation, lung scarring, and 
inflammation of the thyroid gland and kidneys may 
be present in women with autoimmune hepatitis 
• CH associated aplastic anemia may occur 2–3 
months after an acute attack 
• Superinfection and coinfection with HDV results in 
more severe complications compared to infection 
with HBV alone.  
en.wikipedia.org/wiki/Hepatitis  
Clinical Investigation                                                  
Chronic Hepatitis: Alcoholic 1 
• Alcoholic CH characterized by a myriad of symptoms 
(feeling unwell, enlargement of the liver, ascites, 
and modest elevation of liver enzyme levels 
• Alcoholic CH can vary from mild with only liver 
enzyme elevation to severe liver inflammation with 
development of jaundice, prolonged prothrombin 
time, and even liver failure  
en.wikipedia.org/wiki/Hepatitis  
Clinical Investigation                                                  
Chronic Hepatitis: Alcoholic 2 
• Severe cases are characterized by either dulled 
consciousness or the combination of elevated 
bilirubin levels and prolonged prothrombin time; 
the mortality rate in both severe categories is 50% 
• Alcoholic CH is distinct from cirrhosis caused by 
long-term alcohol consumption.     
• Neuropsychiatric features: asymmetric tremor, 
personality changes, dystonia, spasticity, rigidity, 
emotional lability, impulsiveness, etc. 
en.wikipedia.org/wiki/Hepatitis  
Clinical Investigation                                                  
Chronic Hepatitis: Autoimmune 1  
• Individuals with autoimmune CH often have no 
initial symptoms and the disease is detected by 
abnormal liver function tests 
• Common initial symptoms include fatigue or muscle 
aches or signs of acute liver inflammation including 
fever, jaundice, and right upper quadrant abdominal 
pain, and occasionally systemic symptoms such as 
arthralgias, myalgias, polyserositis and 
thrombocytopenia  
en.wikipedia.org/wiki/Hepatitis  
Clinical Investigation                                                  
Chronic Hepatitis: Autoimmune 2 
• Patients usually present with evidence of moderate 
to severe hepatitis with elevated serum ALT and AST 
activities in the setting of normal to marginally 
elevated alkaline phosphatase and 
gammaglutamyltranspeptidase activities 
• The disease may occur in any ethnic group and at 
any age, but is most often diagnosed in patients 
between age 40 and 50 
• There is a strong female predominance. 
en.wikipedia.org/wiki/Hepatitis  
Clinical Investigation                                                  
Chronic Hepatitis: Wilson Disease 2   
• The major patterns of hepatic involvement: active 
CH, cirrhosis and fulminant hepatic failure 
• Neuropsychiatric features: asymmetric tremor, 
excessive salivation, ataxia, masklike facies, 
clumsiness with the hands, personality changes, 
dystonia, seizures, rigidity, emotional lability, etc. 
• Musculoskeletal manifestations: osteoarthritis, 
osteoporosis, osteomalacia, rickets, spontaneous 
fractures  
en.wikipedia.org/wiki/Hepatitis  
Clinical Investigation                                                  
Chronic Hepatitis: Wilson Disease 1    
• Hematologic and renal manifestations: intravascular 
hemolysis, urolithiasis, hematuria 
• Kayser-Fleischer rings: the deposition of copper in 
the Descemet membrane in the limbus of the 
cornea 
• Skin pigmentation and a bluish discoloration at the 
base of the fingernails (azure lunulae).  
en.wikipedia.org/wiki/Hepatitis  
Clinical Investigation                                                  
Chronic Hepatitis: Wilson Disease    
Kayser-Fleischer 
rings.            
http://plasticsurgerykey.com/wp-content/uploads/2016/06/m_gold8_c150f006.png webeye.ophth.uiowa.edu/eyeforum/cases-i/case97/97-1a-lrg.jpg 
Skin pigmentation and a 
bluish discoloration at the 
base of the fingernails (azure 
lunulae).  
Clinical Investigation                                                  
The natural history of chronic hepatitis B 1  
Stage 1: high viral loads and immune tolerance; in 
acute infection, this corresponds to the incubation 
period, but with neonatal chronic infection, this 
period often lasts for decades 
Stage 2: an immunologic response develops leading to 
hepatocyte necrosis; may persist for 10-20 years and 
lead to cirrhosis  
journalofclinicalvirology.com/article/S1386-6532(05)80024-1/abstract  
Clinical Investigation                                                  
The natural history of chronic hepatitis B 2  
Stage 3: the immune response decreases the number 
of infected cells; HBeAg is no longer detectable, a 
marked decrease in HBV viral load is observed, and 
aminotransferase levels become normal; some 
patients continue to have high levels of serum HBV 
DNA and amino-transferases (referred to as HBeAg-
negative chronic hepatitis)  
journalofclinicalvirology.com/article/S1386-6532(05)80024-1/abstract  
Clinical Investigation                                                  
The natural history of chronic hepatitis B 3 
Stage 4: patients become negative for HBeAg and 
positive for anti-HBs, and HBV DNA is usually no 
longer detectable in serum; patients with active HBV 
replication are at increased risk for cirrhosis, hepatic 
decompensation and hepatocellular carcinoma.  
journalofclinicalvirology.com/article/S1386-6532(05)80024-1/abstract  
Clinical Investigation                                                  
Chronic Hepatitis: Activity 1 
Grade 0: no significant inflammation or necrosis 
Grade 1 (minimal activity): portal inflammation with 
predominantly mononuclear cells almost entirely 
confined to the portal areas, no interface hepatitis or 
lobular inflammatory foci 
Grade 2 (mild activity): mild portal inflammation, 
interface hepatitis, and scant lobular spotty necrosis  
http://emedicine.medscape.com/article/1610728-overview#a6 
Clinical Investigation                                                  
Chronic Hepatitis: Activity 2 
Grade 3 (moderate activity): moderate portal 
inflammation, interface hepatitis, and lobular spotty 
necrosis 
Grade 4 (severe activity): marked portal inflammation, 
interface hepatitis, and lobular necrosis, including 
bridging necrosis.  
http://emedicine.medscape.com/article/1610728-overview#a6 
Clinical Investigation                                                  
Chronic Hepatitis: Fibrosis 
Stage 0: no fibrosis  
Stage 1: fibrous portal expansion  
Stage 2: periportal fibrous extension  
Stage 3: fibrous septa formation, including portal-to-
central bridging fibrosis  
Stage 4: cirrhosis.  
http://emedicine.medscape.com/article/1610728-overview#a6 
USMLE TEST 
A 31-year-old woman with well-controlled hypertension and history of 
compensated liver disease secondary to hepatitis C virus (HCV) has just 
learned she is 4 weeks pregnant. Her current medications include 
interferon, ribavirin, and hydrochlorothiazide. Two weeks ago, she was 
vaccinated for hepatitis A and hepatitis B. Assuming the patient's 
hepatic function is stable throughout her pregnancy, which of the 
following poses the greatest risk for the patients' future child?   
1.  Infection with HCV from vertical transmission, 2.  Infection with HCV 
from breast feeding, 3.  Adverse birth outcomes due to patient's 
medications, 4.  Adverse birth outcomes due to patient's vaccination 
history, 5.  Intrauterine growth restriction due to patient's hepatitis C 
status  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 3   
The most concerning aspect of this patient's history is use of 
ribavirin. Ribavirin is highly teratogenic and contraindicated during 
pregnancy.   
Incorrect answers: 
1: Overall incidence of vertical transmission of HCV is 
approximately 2-5%. 
2: HCV is not thought to be transmitted through breast feeding, 
although HCV RNA can be detected in colostrum. 
4: All patients with chronic hepatitis C, regardless of pregnancy, 
should be vaccinated for Hepatitis A and B if not immune already. 
5: Intrauterine growth restriction is not known to be related to 
maternal HCV infection. 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Complications                                                 
Chronic Hepatitis  
http://www.nhs.uk/Conditions/Hepatitis-B/Pages/Complications.aspx 
1  Fibrosis  
2  Cirrhosis of the Liver  
3  Cancer of the Liver  
4 Liver Failure  
5 5  Glomerulonephritis  
6 6  Cryoglobulinemia  
7 7  Hepatic Encephalopathy  
8 8  Portal Hypertension 
9 9  Porphyria 
10 10  Viral Co-Infection  
USMLE TEST 
A 32-year-old female presents to the emergency room with jaundice 
and altered mental status. She is afebrile with all other vital signs 
normal. When she extends her wrists her hands tremor. Initial labs 
reveal markedly elevated transaminases and prolonged prothrombin 
time. Total bilirubin is 6mg/dL and serum creatinine is 3 mg/dL. The 
patient's husband reports that she pricked herself with a needle in a 
hospital where she was volunteering several weeks ago. She is admitted 
to the intensive care unit with institution of supportive cares, but her 
condition continues to deteriorate, with further elevation in her 
bilirubin and INR and worsening encephalopathy. What is the 
appropriate next step in management?   
 
1.  Administer N –acetylcysteine, 2.  ERCP, 3.  Evaluation for emergent 
liver transplantation, 4.  Hepatic artery embolization, 5.  Portohepatic 
shunt procedure  https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 3   
This patient has fulminant liver failure, likely from acute hepatitis B infection 
from dirty needle exposure. Emergent liver transplant may be required for 
fulminant liver failure that progresses despite supportive cares. 
Incorrect answers: 
1: N-Acetylcysteine may be administered in acetaminophen overdose and may 
improve transplant-free survival in other forms of acute liver failure with mild 
encephalopathy, but definitive therapy is liver transplantation, 2: ERCP would 
be helpful in an ascending cholangitis caused by an obstructive stone, but has 
no role for fulminant viral hepatitis, 4: Hepatic artery embolization may be 
used for some primary hepatic tumors and neuroendocrine tumors that 
metastasize to the liver, but would not be helpful in fulminant liver failure from 
viral hepatitis, 5: A portohepatic shunt may be used in cases of worsening 
portal hypertension but does not have a role in acute liver failure. 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Diagnosis                                             
Chronic Hepatitis 1   
• Diagnosis is made by assessing an individual's 
symptoms, physical exam, and medical history, in 
conjunction with blood tests, liver biopsy, and 
imaging 
• Blood testing includes blood chemistry, liver 
enzymes, serology and nucleic acid testing 
• Abnormalities in blood chemistry and enzyme 
results may be indicative of certain causes or stages 
of hepatitis  
 en.wikipedia.org/wiki/Hepatitis  
Diagnosis                                             
Chronic Hepatitis 2  
• Imaging can identify steatosis of the liver but liver 
biopsy is required to demonstrate fibrosis and 
cirrhosis 
• A biopsy is unnecessary if the clinical, laboratory, 
and radiologic data suggests hepatitis.  
 en.wikipedia.org/wiki/Hepatitis  
Diagnosis                                             
Chronic Hepatitis: Special Blood  Testing 1  
• Hepatitis B: surface antigen (HBsAg), hepatitis B 
core antigen (HBcAg),  IgM antibodies specific to 
the hepatitis B core antigen (anti-HBc IgM), 
hepatitis B e (a viral protein that is secreted by 
hepatitis B infected cells) antigen (HBeAg); the 
presence of HBeAg in a host's serum is associated 
with much higher rates of viral replication and 
enhanced infectivity; however, variants of the 
hepatitis B virus do not produce the 'e' antigen, so 
this rule does not always hold true  
en.wikipedia.org/wiki/Hepatitis_C  en.wikipedia.org/wiki/Hepatitis  
Diagnosis                                             
Chronic Hepatitis: Special Blood  Testing 2 
• Hepatitis C: HCV antibody enzyme immunoassay or 
ELISA, recombinant immunoblot assay, and 
quantitative HCV RNApolymerase chain reaction 
(PCR); HCV RNA can be detected by PCR typically 
one to two weeks after infection, while antibodies 
can take substantially longer to form and thus be 
detected  
en.wikipedia.org/wiki/Hepatitis_C  en.wikipedia.org/wiki/Hepatitis  
Diagnosis                                             
Chronic Hepatitis: Special Blood  Testing 3 
• Hepatitis D: HDAg in two forms; a large (L)-HDAg, 
and a small (S)-HDAg of 24kDa. HDAg-S is produced 
in the early stages of an infection and enters the 
nucleus and supports viral replication. HDAg-L, in 
contrast, is produced during the later stages of an 
infection, acts as an inhibitor of viral replication, 
and is required for assembly of viral particles.   
en.wikipedia.org/wiki/Hepatitis_C  en.wikipedia.org/wiki/Hepatitis  
Diagnosis                                             
Chronic Hepatitis: Special Blood  Testing 4 
• Autoimmune hepatitis: antinuclear antibody (ANA), 
anti-smooth muscle antibody (SMA), liver/kidney 
microsomal antibody (LKM-1, LKM-2, LKM-3), anti 
soluble liver antigen and liver–pancreas antigen 
(SLA/LP) and anti-mitochondrial antibody (AMA)), 
increased Immunoglobulin G level. The diagnosis 
always requires a liver biopsy  
en.wikipedia.org/wiki/Hepatitis_C  en.wikipedia.org/wiki/Hepatitis  
Diagnosis                                             
Chronic Hepatitis B: Typical Serological Course   
http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/hepatology/hepatitis-b/images/hep-b-fig2.jpg 
Diagnosis                                             
Chronic Hepatitis B: Liver Chemistry Test  
 en.wikipedia.org/wiki/Hepatitis  
Liver chemistry test    Clinical implication of 
abnormality  
Alanine transaminase   
Aspartate transaminase    Hepatocellular damage  
Lactate dehydrogenase  
Bilirubin  
Alkaline phosphatase  
Gamma-glutamyl transpeptidase   Cholestasis   
Bile acids  
Prothrombin time     Impaired synthetic 
function  
Albumin    
Diagnosis                                             
Chronic Hepatitis: Imaging Studies   
https://www.spandidos-publications.com/10.3892/etm.2011.255 
Magnetic resonance 
images in a 51-year-
old woman with 
chronic hepatitis (A 
and B) and a 65-
year-old woman 
with liver cirrhosis (C 
and D).  
Diagnosis                                            
Chronic Hepatitis: Biopsy 1 
http://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/hepatitis/overview-of-chronic-hepatitis 
• Unlike in acute hepatitis, biopsy is necessary  
• Mild cases may have only minor hepatocellular 
necrosis and inflammatory cell infiltration, usually 
in portal regions  
• In more severe cases, biopsy shows periportal 
necrosis with mononuclear cell infiltrates 
accompanied by variable periportal fibrosis and bile 
duct proliferation   
Diagnosis                                            
Chronic Hepatitis: Biopsy 2 
http://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/hepatitis/overview-of-chronic-hepatitis 
• In most cases, the specific cause of chronic hepatitis 
cannot be discerned via biopsy alone, although 
cases caused by HBV can be distinguished by the 
presence of ground-glass hepatocytes and special 
stains for HBV components 
• Autoimmune cases have a more pronounced 
infiltration by lymphocytes and plasma cells.   
Diagnosis                                             
Chronic Hepatitis:  Histopathologic Features    
https://www.pathology.med.umich.edu/greensonlab/severechronhep.jpg 
Severe Chronic Viral Hepatitis. 
Diagnosis                                             
Chronic Hepatitis: Wilson Disease 1    
emedicine.medscape.com/article/183456-overview  
• Serum ceruloplasmin levels are less than 20 mg/dL 
(reference range, 20-40 mg/dL) in approximately 
90% of all patients 
• The urinary copper excretion rate is greater than 
100 mcg/day (reference range, < 40 mcg/day) in 
most patients 
• In a patient with Kayser-Fleischer rings, a serum 
ceruloplasmin level < 0 mg/dL and 24-hoyr urine 
copper excretion >40 mcg/day establish the 
diagnosis  
Diagnosis                                             
Chronic Hepatitis: Wilson Disease 2  
emedicine.medscape.com/article/183456-overview  
• Hepatic copper concentration (criterion standard) 
on a liver biopsy specimen is >250 mcg/g of dry 
weight even in asymptomatic patients 
• Radiolabeled copper testing directly assays hepatic 
copper metabolism 
• Genetic testing is limited to screening of family 
members for an identified mutation detected in the 
index patient  
Diagnosis                                             
Chronic Hepatitis: Wilson Disease 3 
emedicine.medscape.com/article/183456-overview  
• Brain imaging shows characteristic findings; MRI 
appears to be more sensitive than CT in detecting 
early lesions 
• Resting ECG abnormalities include left ventricular or 
biventricular hypertrophy, early repolarization, ST 
segment depression, T-wave inversion, and various 
arrhythmias.  
Diagnosis                                             
Chronic Hepatitis: Wilson Disease’ Histopathologic Features  
http://pathologyoutlines.com/caseofweek/case388image10Rhodanine.jpg 
Rhodamine stain for copper. 
USMLE TEST 
A 30-year-old G1P0 at 26 weeks presents to your office 
concerned about a recent news report relating to a pregnant 
woman with hepatitis. Per the patient, this woman contracted 
hepatitis in her third trimester and, within several weeks, 
died. Which viral hepatitis has the highest rate of progression 
to fulminant hepatitis in pregnant women?  
 
1.  Hepatitis A, 2.  Hepatitis B, 3.  Hepatitis C, 4.  Hepatitis D,  
5.  Hepatitis E  
 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 5   
 In pregnant women, hepatitis E (HEV) has an unusually high rate of 
progression to fulminant hepatitis. 
Incorrect answers: 
1, 2, 3, 4: Pregnant women with HEV hepatitis appear to have worse 
obstetric and fetal outcomes compared to pregnant women with other 
viral hepatitis infections. 
 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Management                                             
Chronic Hepatitis: Lifestyle Modifications   
• Lifestyle modifications are strongly recommended 
for patients with chronic hepatitis 
• Even when efficacious pharmacologic interventions 
are identified, lifestyle changes will likely represent 
an adjuvant treatment because new drugs are 
inevitably expensive and may have unanticipated 
adverse effects after prolonged use 
• Lifestyle modifications typically encompass both 
dietary intervention and physical activity goals.    
ncbi.nlm.nih.gov/pmc/articles/PMC3127780/  
Management                                             
Chronic Hepatitis: Hepatitis B, D 1    
• Patients with persistently elevated serum alanine 
aminotransferase, and HBV DNA levels are 
candidates for therapy 
• Treatment lasts from six months to a year, 
depending on medication and genotype 
• Although none of the available drugs can clear the 
infection, they can stop the virus from replicating, 
thus minimizing liver damage  
en.wikipedia.org/wiki/Myrcludex_Ben.wikipedia.org/wiki/Hepatitis_B  
Management                                             
Chronic Hepatitis: Hepatitis B, D 2 
• There are seven medications licensed for treatment 
of hepatitis (lamivudine, adefovir, tenofovir, 
telbivudine, entecavir, interferon alpha2a and 
PEGylated interferon alpha-2a) 
• Interferon treatment may produce an e antigen 
seroconversion rate of 37% in genotype A but only a 
6% seroconversion in type D 
• The drug myrcludex B, which inhibits virus entry 
into hepatocytes, is in clinical trials as of October 
2015.   
en.wikipedia.org/wiki/Myrcludex_Ben.wikipedia.org/wiki/Hepatitis_B  
Management                                             
Chronic Hepatitis: Hepatitis C    
•  HCV induces chronic infection in 50–80% of 
infected persons 
• Approximately 40–80% of these clear with 
treatment 
• In rare cases, infection can clear without treatment 
• Those with chronic hepatitis C are advised to avoid 
alcohol and medications toxic to the liver, and to be 
vaccinated for hepatitis A and hepatitis B 
• Ultrasound surveillance for hepatocellular 
carcinoma is recommended in those with 
accompanying cirrhosis.   en.wikipedia.org/wiki/Hepatitis_C  
Management                                             
Chronic Hepatitis: Alcoholic Hepatitis    
•  Clinical practice guidelines by the American College 
of Gastroenterology have recommended 
corticosteroid treatment with prednisolone 40 mg 
daily for four weeks followed by a taper. 
Prednisolone gave a small reduction in mortality at 
28 days but this did not reach significance 
• Pentoxifylline (a xanthine derivative) is used to 
improve blood flow  for 4 weeks to prevent one 
patient from dying. Pentoxifylline did not improve 
survival alone or in combination.  
https://en.wikipedia.org/wiki/Alcoholic_hepatitis  
Management                                             
Chronic Hepatitis: Autoimmune Hepatitis 1     
• Treatment may involve the prescription of 
immunosuppressive glucocorticoids, with or 
without azathioprine, and remission can be 
achieved in up to 60–80% of cases, although many 
will eventually experience a relapse 
• Budesonide has been shown to be more effective in 
inducing remission than prednisone, and result in 
fewer adverse effects  
https://en.wikipedia.org/wiki/Autoimmune_hepatitis 
Management                                             
Chronic Hepatitis: Autoimmune Hepatitis 2     
• Patients who do not respond to glucocorticoids and 
azathioprine may be given other 
immunosuppressives like mycophenolate, 
cyclosporin, tacrolimus,methotrexate, etc.  
• Liver transplantation may be required if patients do 
not respond to drug therapy or when patients 
present with fulminant liver failure. 
https://en.wikipedia.org/wiki/Autoimmune_hepatitis 
USMLE TEST 
A 42-year-old male commercial sex worker comes to the 
emergency department complaining of persistent fatigue and 
malaise for the past three weeks. On physical exam, you 
observe a lethargic male with icteric sclera and hepatomegaly. 
AST and ALT are elevated at 600 and 750, respectively. HBV 
surface antigen is positive. Albumin is 3.8 g/dL and PT is 12. A 
liver biopsy shows significant inflammation with bridging 
fibrosis. What is the most appropriate treatment at this 
time?   
1.  Zidovudine, 2.  Ribavirin, 3.  Maraviroc, 4.  Combined 
lamivudine and interferon, 5.  Combined interferon and 
ribavirin  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 4   
Combined therapy of interferon and lamivudine is warranted 
in patients with hepatitis B (HBV) who show signs of active 
disease.  
Incorrect answers: 
1, 3: Zidovudine and Maraviroc are used in the treatment of 
HIV, 2, 5: Combined ribavirin and interferon is the treatment 
for HCV. 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Management                                             
Chronic Hepatitis: Wilson Disease 1     
• The mainstay of therapy is lifelong use of chelating 
agents (e.g., penicillamine, trientine) 
• Symptoms, particularly neurologic ones, may 
worsen with initiation of chelation 
• Surgical decompression or transjugular intrahepatic 
shunting (TIPS) is reserved for recurrent or 
uncontrolled variceal bleeding unresponsive to 
standard conservative measures  
emedicine.medscape.com/article/183456-overview  
Management                                             
Chronic Hepatitis: Wilson Disease 2     
• Orthotopic liver transplantation is curative 
• Other treatments (anticholinergics, baclofen, GABA 
antagonists, levodopa, antiepileptics, neuroleptics ) 
• Protein restriction, lactulose, or both to treat 
hepatic. 
emedicine.medscape.com/article/183456-overview  
Prognosis  
Chronic Hepatitis  
 • Prognosis depends heavily on the disease or 
condition that is causing the symptoms 
• Chronic damage to the liver can result in the 
formation of scar tissue (fibrosis) and can result in 
nodules that block the liver from functioning 
properly (cirrhosis) 
• Another complication of chronic hepatitis is liver 
cancer, specifically hepatocellular carcinoma 
• Some cases can require a liver transplant.  
 en.wikipedia.org/wiki/Hepatitis  
Prophylaxis  
Chronic Hepatitis 1  
• Vaccines are available to prevent hepatitis B 
• Vaccines to prevent hepatitis B have been available 
since 1986 and have been incorporated into at least 
177 national immunization programs for children 
• Immunity is achieved in greater than 95% of 
children and young adults receiving the three-dose 
recombinant virus vaccine 
• Vaccination within 24 hours of birth can prevent 
transmission from an infected mother  
en.wikipedia.org/wiki/Hepatitis  
Prophylaxis  
Chronic Hepatitis 2  
• Adults over 40 years of age have decreased immune 
response to the vaccine 
• The vaccine for hepatitis B protects against hepatitis 
D virus because of the latter's dependence on the 
presence of hepatitis B virus for it to replicate.    
en.wikipedia.org/wiki/Hepatitis  
Abbreviations  
CH - Chronic hepatitis 
NAFLD - non-alcoholic fatty liver disease 
Diagnostic and treatment guidelines 
Chronic Hepatitis 
Overview of Chronic Hepatitis 
AASLD Guidelines for Treatment of Chronic Hepatitis B 
Hepatitis B Treatment & Management 
Asian-Pacific clinical practice guidelines on the management of hepatitis 
B: a 2015 update 
Management of Chronic Hepatitis B: An Overview of Practice Guidelines 
for Primary Care Providers 
Hepatitis 
 
 
